ArticleBMC pharmacology & toxicology2025

Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis.

Xingyu Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.